Class I phosphoinositide 3-kinases in normal and pathologic hematopoietic cells
François Vergez1, Christian Recher, Bernard Payrastre
1Cancer Research Center of Toulouse and Laboratoire d'Hématologie, Hôpital de Toulouse, France.
Current Topics in Microbiology and Immunology
|October 23, 2012
Summary
Class I phosphoinositide 3-kinases are crucial for cell functions and are implicated in various cancers. This review explores their role in blood cell development and leukemia, highlighting therapeutic potential.
Area of Science:
- Cell Biology
- Oncology
- Hematology
Background:
- Class I phosphoinositide 3-kinases (PI3Ks) generate phosphatidylinositol 3,4,5-trisphosphate, a key second messenger.
- PI3K signaling is vital for cell proliferation, survival, metabolism, and motility.
- Aberrant PI3K activation is common in human cancers, including hematologic malignancies, making them therapeutic targets.
Purpose of the Study:
- To provide an overview of the role of Class I PI3Ks in hematopoietic stem cells.
- To examine the involvement of PI3Ks in hematopoietic lineage development.
- To discuss the significance of PI3Ks in leukemia, particularly acute myeloid leukemia, and their therapeutic implications.
Main Methods:
- Literature review of Class I phosphoinositide 3-kinases.
- Analysis of PI3K roles in hematopoietic stem cells and lineage development.
- Summary of PI3K involvement in leukemia pathogenesis and therapeutic strategies.
Main Results:
- Class I PI3Ks are critical regulators of hematopoietic stem cell function and blood cell differentiation.
- Dysregulation of PI3K signaling contributes to the development and progression of leukemia.
- Targeting PI3K pathways offers potential therapeutic strategies for hematologic malignancies.
Conclusions:
- Class I PI3Ks play a fundamental role in normal hematopoiesis and its aberrant activation in leukemia.
- Understanding PI3K signaling in blood cancers is crucial for developing effective cancer therapies.
- Targeting PI3K offers a promising avenue for treating leukemia and other hematologic disorders.
More Related Videos
10:52Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation
Published on: January 6, 2016
07:26Single-molecule Super-resolution Imaging of Phosphatidylinositol 4,5-bisphosphate in the Plasma Membrane with Novel Fluorescent Probes
Published on: October 15, 2016
Related Concept Videos
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...